Novo Nordisk shares rebound as FDA targets illegal drug copies
By Jacob Gronholt-Pedersen COPENHAGEN, Feb 6 (Reuters) - Shares in Danish drugmaker Novo Nordisk gained 5.4% on Friday, recovering some of the previous two sessions' steep losses, after the U.S. Food and Drug Administration (FDA) pledged to address mass-marketing...
Reuters